ETNB
Price
$6.75
Change
+$0.17 (+2.58%)
Updated
Jan 22 closing price
Capitalization
793.68M
55 days until earnings call
PLRX
Price
$10.90
Change
-$0.02 (-0.18%)
Updated
Jan 23, 10:37 AM (EDT)
Capitalization
664.52M
40 days until earnings call
Ad is loading...

ETNB vs PLRX

Header iconETNB vs PLRX Comparison
Open Charts ETNB vs PLRXBanner chart's image
89bio
Price$6.75
Change+$0.17 (+2.58%)
Volume$880.26K
Capitalization793.68M
Pliant Therapeutics
Price$10.90
Change-$0.02 (-0.18%)
Volume$100
Capitalization664.52M
ETNB vs PLRX Comparison Chart
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. PLRX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Hold and PLRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (ETNB: $6.75 vs. PLRX: $10.92)
Brand notoriety: ETNB and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 67% vs. PLRX: 115%
Market capitalization -- ETNB: $793.68M vs. PLRX: $664.52M
ETNB [@Biotechnology] is valued at $793.68M. PLRX’s [@Biotechnology] market capitalization is $664.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 1 TA indicator(s) are bullish while PLRX’s TA Score has 2 bullish TA indicator(s).

  • ETNB’s TA Score: 1 bullish, 5 bearish.
  • PLRX’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than ETNB.

Price Growth

ETNB (@Biotechnology) experienced а +7.66% price change this week, while PLRX (@Biotechnology) price change was -13.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

ETNB is expected to report earnings on May 07, 2025.

PLRX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($794M) has a higher market cap than PLRX($665M). ETNB YTD gains are higher at: -13.683 vs. PLRX (-17.084). PLRX has higher annual earnings (EBITDA): -197.04M vs. ETNB (-279.65M). ETNB (424M) and PLRX (405M) have equal amount of cash in the bank . ETNB has less debt than PLRX: ETNB (37.6M) vs PLRX (60.2M). ETNB (0) and PLRX (0) have equivalent revenues.
ETNBPLRXETNB / PLRX
Capitalization794M665M119%
EBITDA-279.65M-197.04M142%
Gain YTD-13.683-17.08480%
P/E RatioN/AN/A-
Revenue00-
Total Cash424M405M105%
Total Debt37.6M60.2M62%
TECHNICAL ANALYSIS
Technical Analysis
ETNBPLRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
87%
Bullish Trend 16 days ago
88%
Momentum
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 16 days ago
90%
MACD
ODDS (%)
Bearish Trend 16 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 16 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 16 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
87%
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 16 days ago
86%
View a ticker or compare two or three
Ad is loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PASTX53.891.17
+2.22%
T. Rowe Price Science & Tech Adv
AIVEX16.870.04
+0.24%
American Funds International Vntg F-1
SVYAX11.51N/A
N/A
SEI US Managed Volatility A (SIIT)
BBISX31.41-0.22
-0.70%
Sterling Capital Behav Lg Cp Val Eq Intl
IRFCX7.95-0.06
-0.75%
Cohen & Steers International Realty C

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+2.58%
AKRO - ETNB
62%
Loosely correlated
-2.27%
IDYA - ETNB
48%
Loosely correlated
-0.04%
PLRX - ETNB
47%
Loosely correlated
-1.36%
NTLA - ETNB
47%
Loosely correlated
+10.76%
ALLO - ETNB
46%
Loosely correlated
+4.35%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-1.36%
RCKT - PLRX
51%
Loosely correlated
+3.15%
PRME - PLRX
50%
Loosely correlated
+9.28%
CRSP - PLRX
50%
Loosely correlated
+6.48%
NTLA - PLRX
50%
Loosely correlated
+10.76%
TRDA - PLRX
49%
Loosely correlated
-3.98%
More